KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 126 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $3,825,000 | -2.5% | 1,125,202 | +7.8% | 0.00% | 0.0% |
| Q2 2018 | $3,924,000 | +3.5% | 1,043,876 | +12.6% | 0.00% | 0.0% |
| Q1 2018 | $3,790,000 | -10.6% | 926,708 | +1.6% | 0.00% | 0.0% |
| Q4 2017 | $4,241,000 | -33.1% | 912,179 | +2.1% | 0.00% | -50.0% |
| Q3 2017 | $6,341,000 | +2.9% | 893,176 | +4.8% | 0.00% | 0.0% |
| Q2 2017 | $6,161,000 | +23.7% | 852,162 | +5.4% | 0.00% | 0.0% |
| Q1 2017 | $4,982,000 | +13.3% | 808,787 | +7.8% | 0.00% | 0.0% |
| Q4 2016 | $4,398,000 | +14.6% | 750,517 | +3.8% | 0.00% | 0.0% |
| Q3 2016 | $3,839,000 | -19.4% | 723,016 | +0.5% | 0.00% | -33.3% |
| Q2 2016 | $4,761,000 | +45.7% | 719,245 | +2.8% | 0.00% | +50.0% |
| Q1 2016 | $3,268,000 | -2.5% | 699,895 | +5.4% | 0.00% | 0.0% |
| Q4 2015 | $3,352,000 | +44.9% | 663,857 | +1.0% | 0.00% | +100.0% |
| Q3 2015 | $2,313,000 | -63.3% | 657,146 | +3.9% | 0.00% | -75.0% |
| Q2 2015 | $6,310,000 | -20.9% | 632,268 | +0.8% | 0.00% | -20.0% |
| Q1 2015 | $7,982,000 | +6.0% | 627,032 | +17.8% | 0.01% | +25.0% |
| Q4 2014 | $7,531,000 | +4.7% | 532,270 | +1.8% | 0.00% | -20.0% |
| Q3 2014 | $7,190,000 | -9.8% | 522,982 | +1.0% | 0.01% | 0.0% |
| Q2 2014 | $7,967,000 | -5.2% | 518,057 | +5.1% | 0.01% | -16.7% |
| Q1 2014 | $8,401,000 | +65.4% | 493,041 | +25.7% | 0.01% | +50.0% |
| Q4 2013 | $5,080,000 | +43.7% | 392,306 | +12.1% | 0.00% | +33.3% |
| Q3 2013 | $3,535,000 | +40.1% | 349,956 | +3.6% | 0.00% | +50.0% |
| Q2 2013 | $2,524,000 | – | 337,848 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |